Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Repositioning of bromocriptine for treatment of acute myeloid leukemia

Fig. 3

Bromocriptine treatment spared healthy blood cells. a Healthy CD33-positive myeloid mature cells from peripheral blood of healthy donors were treated for 72 h with vehicle control or 10 µM bromocriptine. Cell viability was measured by flow cytometry. b Lineage-depleted umbilical cord blood cells were treated with vehicle control or 10 µM bromocriptine for 18 h and cultured in methylcellulose. Total number of colonies (left) or frequency of each colony subtype (right) refer to control is represented. Bars represent mean value of at least biological triplicates. Error bars correspond to SEM. ***p < 0.005; ****p < 0.001

Back to article page